Verimed Ltd 15603730 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is pharmaceutical advisory Digita Accounts Production Advanced 6.30.9574.0 true 15603730 2025-04-01 2026-03-31 15603730 2026-03-31 15603730 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 15603730 bus:Micro-entities 2025-04-01 2026-03-31 15603730 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 15603730 bus:FilletedAccounts 2025-04-01 2026-03-31 15603730 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 15603730 bus:RegisteredOffice 2025-04-01 2026-03-31 15603730 bus:Director1 2025-04-01 2026-03-31 15603730 bus:Director2 2025-04-01 2026-03-31 15603730 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 15603730 countries:AllCountries 2025-04-01 2026-03-31 15603730 2024-03-29 2025-03-31 15603730 2025-03-31 15603730 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 15603730

Verimed Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2026

 

Verimed Ltd

(Registration number: 15603730)
Balance Sheet as at 31 March 2026

2026
£

2025
£

Fixed assets

133

227

Current assets

9,048

26,142

Prepayments and accrued income

48

55

Creditors: Amounts falling due within one year

(12,501)

(22,497)

Net current (liabilities)/assets

(3,405)

3,700

Total assets less current liabilities

(3,272)

3,927

Accruals and deferred income

(204)

(189)

 

(3,476)

3,738

Capital and reserves

(3,476)

3,738

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
20-22 Wenlock Road
London
N1 7GU
England

These financial statements were authorised for issue by the Board on 13 September 2026.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2025 - 2).

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

Verimed Ltd

(Registration number: 15603730)
Balance Sheet as at 31 March 2026

Approved and authorised by the Board on 13 September 2026 and signed on its behalf by:
 

.
D Lindsay
Director

.
AR Lindsay
Director